Skip to main content

Table 1 Clinical characteristics of the 71 ovarian cancer cases

From: Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer

 

Category

No. (%)

Race and ethnicity

Non-Hispanic White

55 (77.5)

Hispanic/Latina

11 (15.5)

Asian

5 (7.0)

Median age of diagnosis (years)

58

 

Age at diagnosis (years)

 < 50

7 (9.9)

50–69

53 (74.6)

 ≥ 70

11 (15.5)

Median overall survival (months)

37.8

 

Median RFSa (months)

16.5

 

Median follow-upb (months)

55.8

 

Stage

IIIA-IIIC

62 (87.3)

IV

9 (12.7)

Debulking status

Optimal

61 (85.9)

Suboptimal

7 (9.9)

Unable to debulk

1 (1.4)

Unknown

2 (2.8)

Chemotherapy therapy

Adjuvant

57 (80.3)

Neoadjuvant

14 (19.7)

Chemotherapy delivery

Intraperitoneal

28 (39.4)

Intravenous

43 (60.6)

Tumors investigated

Primary

64

Metastatic

50

Tumors per patient

1

44

2

17

 ≥ 3

10

  1. aRelapse-free survival (RFS) as of 6/22/21
  2. bTime to first recurrence from last chemo dose. No recurrence as of 06/22/21